Bruxism, temporomandibular disorders and consequences in patients with Parkinson*s disease

Bruxism, temporomandibular disorders and consequences in patients with Parkinson*s disease - Parkinson*s disease, bruxism and TMD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49742

Enrollment

235

Registered

2019-12-06

Start date

2020-09-25

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tandheelkundig temporomandibular disorders

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients who visit the outpatient clinic for movement disorders of the VUmc hospital with (presumable) PD. - Adults (>18 years old)

Exclusion criteria

Exclusion criteria: - Children or adolescents (

Design outcomes

Primary

Measure	Time frame
- (Definite) bruxism diagnosis - TMD diagnosis (according to the Diagnostic Criteria for TMD; DC/TMD) - Levodopa equivalent daily dose (LEDD) - Pain intensity (GCPS) - Tooth wear screening (TWES) - Depression (BDI-ii) - Anxiety (PASS) - Stress (PHQ-15) - Cognitive function (PD-CRFS and MoCA) - Disease stage (Hoehn & Yahr) - Disease severity (Unified Parkinson*s Disease Rating Scale; UPDRS III) - SCOPA-SLEEP scale	—

Measure

Time frame

- (Definite) bruxism diagnosis - TMD diagnosis (according to the Diagnostic Criteria for TMD; DC/TMD) - Levodopa equivalent daily dose (LEDD) - Pain intensity (GCPS) - Tooth wear screening (TWES) - Depression (BDI-ii) - Anxiety (PASS) - Stress (PHQ-15) - Cognitive function (PD-CRFS and MoCA) - Disease stage (Hoehn & Yahr) - Disease severity (Unified Parkinson*s Disease Rating Scale; UPDRS III) - SCOPA-SLEEP scale

—

Secondary

Measure	Time frame
- Salivary flow, pH and buffer capacity of saliva - Tooth wear screening index (TWES) - Brain imaging, for example presynaptic dopaminergic loss visualized with DAT-SPECT (if applicable)	—

Countries

Netherlands

Outcome results